Literatur
- 1
Sin D D, Man S FP.
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does
the dose matter?.
Eur Respir J.
2003;
21
260-266
- 2
Witte F.
Inhalative Kortikoide reduzieren Mortalität bei COPD.
Pneumologie.
2003;
57
254
- 3
Burge P S, Calverley P MA, Jones P W. et al .
Randomised, double blind, placebo controlled study of fluticasone propionate in patients
with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
BMJ.
2000;
320
1297-1303
- 4
Pauwels R A, Lofdahl C-G, Laitinen L A. et al .
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive
pulmonary disease who continue smoking.
N Engl J Med.
1999;
340
1948-1953
- 5
Cox G, Whitehead L, Dolovich M. et al .
A randomized controlled trial on the effect of inhaled corticosteroids on airways
inflammation in adult cigarette smokers.
Chest.
1999;
115
1271-1277
- 6
O'Byrne P M, Postma D S.
The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
1999;
159
S41-S66
- 7
Keatings V M, Jatakanon A, Worsdell Y M. et al .
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and
COPD.
Am J Respir Crit Care Med.
1997;
155
542-548
- 8
Paggiaro P L, Dahle R, Bakran I. et al .
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate
in patients with chronic obstructive pulmonary disease.
Lancet.
1998;
351
773-780
- 9
Gillissen A, Buhl R, Kardos P. et al .
Inhalierbare Kortikosteroide in der Langzeittherapie der COPD. Stellungnahme eines
Expertengremiums.
Pneumologie.
2000;
54
256-262
- 10
Vestbo J, Sørensen T, Langer P. et al .
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary
disease: a randomised controlled trial.
Lancet.
1999;
355
1819-1823
- 11
Barnes P J.
Inhaled Corticosteroids are not beneficial in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2000;
161
342-344
- 12
Loppow D, Schleiss M B, Kanniess F. et al .
In patients with chronic bronchitis a four week trial with inhaled steroids does not
attenuate airway inflammation.
Resp Med.
2001;
95
115-121
- 13
Niewoehner D E, Erbland M L, Deupree R H. et al .
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary
disease.
N Engl J Med.
1999;
340
1941-1947
- 14
Gillissen A, Buhl R, Kardos P. et al .
Management der akuten Exazerbation der chronisch-obstruktiven Lungenerkrankung (COPD).
Dtsch Med Wschr.
2003;
Im Druck
- 15
Alsaeedi A, Sin D D, McAlister F A.
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a
systematic review of randomized placebo-controlled trials.
Am J Med.
2002;
113
59-65
- 16
Worth H, Buhl R, Cegla U. et al .
Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie
zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und
Lungenemphysem (COPD).
Pneumologie.
2002;
56
704-738
- 17 Hitzenberger G. Compliance. Wien: Blackwell-Wissenschafts-Verlag 1995
- 18
Carone M, Bertolotti G, Anchisi F. et al .
Analysis of factors that characterize health impairment in patients with chronic respiratory
failure. Quality of life in chronic respiratory failure group.
Eur Respir J.
1999;
13
1293-1300
- 19
Lewis M.
The transnational study on oral contraceptives and the health of young women. Methods,
results, new analysis and the healthy user effect.
Human Reproduction Update.
1999;
5
702-720
- 20
Taylor D M, Auble T E, Calhoun W J. et al .
Current outpatient management of asthma shows poor compliance with International Consensus
Guidelines.
Chest.
1999;
116
1638-1645
- 21
Sin D D, Tu J V.
Inhaled corticosteroids and the risk of mortality and readmission in elderly patients
with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2001;
164
580-584
- 22
Soriano J B, Vestbo J, Pride N B. et al .
Survival in COPD patients after regular use of fluticasone propionate and salmeterol
in general practice.
Eur Respir J.
2002;
20
819-825
- 23
Suissa S.
Effectiveness of inhalaed corticosteroids in chronic obstructive pulmonary disease.
Immortal time bias in observational studies.
Am J Respir Crit Care Med.
2003;
168
49-53
- 24
Bourbeau J.
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease.
Eur Respir J.
2003;
21
202-203
- 25
Barnes P J.
Therapy of chronic obstrucitve pulmonary disease.
Pharmacol Ther.
2002;
97
87-94
- 26
Welte T, Gillissen A.
Brauchen wir inhalative Steroide bei chronisch-obstruktiver Lungenerkrankung?.
Med Klinik.
2002;
97
15-19
- 27
Pauwels R A, Buist A S, Calverley P MA. et al .
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive
Pulmonary Disease.
Am J Respir Crit Care Med.
2001;
163
1256-1276Aktuelle Version: www.copdgold.com
Prof. Dr. A. Gillissen
Robert Koch-Klinik · Klinikum „St. Georg”
Nikolai-Rumjanzew-Str. 100
04207 Leipzig
eMail: adrian.gillissen@sanktgeorg.de
